Companies›Fast Moving Consumer Goods›Fast Moving Consumer Goods›Food Products
NSE:AJOONI

AJOONI BIOTECH LIMITED

Fast Moving Consumer Goods › Food Products
₹2.95
at close · 28 Oct 2026
▲ 0.05 (+1.72%)

Latest filings

  1. Company confirms functional website as per SEBI norms · Compliance
  2. Confirmation Certificate filing under SEBI Regulation 74(5) for September 2026 quarter · Compliance
  3. Trading Window Closure for Q2 FY2027 Results Declaration · Compliance
All filings ↓
Ask Nexa about AJOONI BIOTECH LIMITED

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Operates in the animal feed segment of the food products industry, with leadership that has over 15 years of experience in animal husbandry and agriculture. Revenue from operations in FY26 reached Rs. 182.38 crore, up 59% year-on-year, while net profit was Rs. 4.32 crore. Materials account for 81.2% of revenue, indicating a manufacturing-heavy cost base. The company is investing Rs. 18.03 crore in capex (9.9% of revenue), including a storage godown at Khanna, Punjab. It recently secured its biggest-ever order worth Rs. 47.52 crore, although the client, product and delivery timeline were not disclosed in the filing.

Operating scale
FY26 revenue from operations
Rs. 182.38 crFY26
YoY revenue growth
59.02%FY26
Materials share of revenue
81.2%FY26
FY26 capex
Rs. 18.03 cr (9.9% of revenue)FY26
Biggest-ever order secured
Rs. 47.52 crFeb 2026
Preferential issue to promoter Healthy Biosciences
90 lakh shares at Rs. 4.30 each (Rs. 3.87 cr)Jul 2026
Who pays it
Animal husbandry and agriculture customers per industry classification; buyer of the Rs. 47.52 crore order was not named in the filing.
Biggest cost
Raw materials at Rs. 148.05 crore, equal to 81.2% of FY26 revenue.
Kind of business
Manufacturing-intensive, small-cap animal feed and food products company.
Where it sits
Small-cap listed on NSE; specific market share or industry ranking not disclosed in filings.
Market Cap
₹51 Cr
P / E (TTM)
12.3×
EV / EBITDA
7.4×
Div Yield
—
Growth
29.0%▲
Revenue 5y CAGR
PAT +63.2% · EBITDA +39.1%
Quality
7.0%·
ROCE (FY26)
ROE 4.7% · margin 4.8%
Leverage
0.19·
Debt / Equity · low
Net debt ₹17 Cr
Revenue FY21→FY26
3.6×▲
Margin +1.6 pts
₹51 Cr → ₹182 Cr
Cash conversion
-2.44×▼
Operating cash ÷ profit · 5 yrs
₹-29 Cr on ₹12 Cr
Moves on a normal day
1.35%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 7 Animal Feed peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#4/8
P/B#1/5
ROCE#6/6
ROE#5/5
Debt / Equity#3/5
EBITDA margin#5/6
Revenue growth#2/6
Profit growth#4/5

Scorecard

Measured from the filed financials, judged against its Animal Feed peers · as of FY26 — not investment advice

Strengths
Revenue compounding 29% a year over 5 years
Profit compounding 63% a year over 5 years
Profit grew in every one of the last 5 years
Concerns
Returns on capital 7.0%
#6 of 6 in Animal Feed on the latest reported figures
Over 5 years it reported ₹12 Cr of profit and an operating cash outflow of ₹29 Cr — -2.44×
Less than 60p of every ₹1 of profit arrived as cash
EPS grew slower than profit — the share count rose (bonus or dilution)

Charts

How has the market priced it — with filings on the timeline?

AJOONI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from AJOONI BIOTECH LIMITED's filed financials and exchange disclosures

What does AJOONI BIOTECH LIMITED do?

AJOONI BIOTECH LIMITED is a Food Products company listed on NSE, trading under the symbol AJOONI.

Is AJOONI BIOTECH LIMITED profitable?

Yes. Over the trailing twelve months AJOONI BIOTECH LIMITED reported a net profit of ₹3.96 Cr on revenue of ₹215 Cr.

Does AJOONI BIOTECH LIMITED pay a dividend?

Not in the latest reported year — AJOONI BIOTECH LIMITED's dividend payout for FY26 was nil.

Is AJOONI BIOTECH LIMITED debt-free?

No. It reported borrowings of ₹18 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹17 Cr after cash. Debt stands at 0.19× equity. That is lower than 50% of its 5 Animal Feed peers.

Is AJOONI BIOTECH LIMITED expensive compared with its peers?

On trailing P/E, AJOONI BIOTECH LIMITED ranks 4 of 8 in Animal Feed — cheaper than 57% of them, against an industry median of 14.7×. This is a position, not a valuation judgement.

How much does the AJOONI BIOTECH LIMITED share price move in a day?

On a typical session AJOONI BIOTECH LIMITED moves 1.35% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

Where can I track AJOONI BIOTECH LIMITED's announcements?

Every NSE and BSE filing by AJOONI BIOTECH LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.